Category Archives: News

Fosun veteran Juxiang Xia joins Sparx Therapeutics

August 10th, 2021 Sparx Therapeutics, an emerging biopharmaceutical company specializing in developing multi-specific antibody and antibody-drug conjugate (ADC) drugs, today announced the appointment of Ms. Juxiang Xia, a former Fosun veteran, as the COO of Sparx Yangzhou. Ms. Xia brings in decades of experience in operation, infrastructure building, governmental affairs, and investing. “We are very proud…
Read more

Former Eli Lilly veteran Dr. Victor Wroblewski joins Sparx Therapeutics as a Senior VP and Head of Biology

Chicago,USA September 1, 2020 Sparx Therapeutics, an emerging biopharmaceutical company specializing in developing multi-specific antibodies to treat solid tumors, today announced the appointment of Dr. Victor Wroblewski, a former Eli Lilly veteran, as a Senior VP and Head of Biology. Dr. Victor Wroblewski brings in decades of deep knowledge and experience in antibody drug development.…
Read more

Sparx Therapeutics-News release 2018-11-8

Sparx Therapeutics & KPC Pharmaceutical Sign Agreement for the Development of anti-Claudin 18.2 Antibodies Sparx Therapeutics, Inc. has signed an agreement with KPC Pharmaceutical to discover and develop a monoclonal antibody against Claudin 18.2 with the potential to treat a range of human diseases including gastric cancer. Under the terms of the agreement, Sparx will…
Read more

Precision Medicine Center Unveiled

China, Sep-10-2018 Central South University Xiangya - Yaoyuan Pharma Precision Medicine Research Center has just been officially founded today. This is yet another newly established world class research center in Hunan province of China, which is expected to bring breakthrough in the fields of precision medicine, medical risk analysis and big-data clinical trial researches. Leadership…
Read more